Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, into molecular subtypes using ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.

PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with Canary Oncoceutics (Canar ...

Noting that recent advances in artificial intelligence and the existence of large-scale experimental data about human biology ...

"GI successfully integrated advanced artificial intelligence into diagnostics and procedures, proving efficiency and patient outcomes without compromising the human touch in care," Nitin Sardana, MD, ...

UPMC Enterprises, the innovation, commercialization and venture capital arm of Pittsburgh-based UPMC, sold its third company this year: Realyze Intelligence, an AI-powered healthcare startup, to Carta ...

Wexford-based biopharmaceutical company Coeptis Therapeutics Holdings Inc. is diversifying itself by launching a new division ...

Cancer researchers are looking at AI to help come up with new therapies to treat Cancer. Dr. Isabella Tai, A Canadian Cancer Society- funded researcher shares her story and why she thinks AI could be ...

"To be one of the first academic medical centers in the United States to do this is remarkable," Dr. Mike Laposata, chair of UTMB Galveston's pathology department said.

Industry and patient representatives debated how the FDA should regulate generative AI in medical devices and address new challenges with the technology, such as the use of complex models that can ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the ...